In this week’s issue of The Savvy Diabetic: 

• • CamDiab earns CE mark for fully closed-loop insulin delivery algorithm
  • Senseonics Receives European Approval for Eversense 365
  • Dexcom G8: Dexcom CEO Hints at its Next-Gen Sensor
  • Is Chronic Inflammation Stealing Your Energy? Let’s Fix It.
  • Scientists: Maybe the “Holy Grail” of Sugar Substitutes
  • Johns Hopkins University President Ron Daniels on living with T1D
  • UVA Data Science researcher leads $4.7M project: AI-powered D management
  • Check out TheSugarScience: promoting scientific T1D discussion
  • They Told Us We Wouldn’t Live This Long: Riva Greenberg & Ginger Vieira
  • Embracing sauna culture can lower dementia risk 

---

---

CamDiab earns CE mark for fully closed-loop insulin delivery algorithm by Sean Whooley for DrugDeliveryBusiness.com, 9 January 2026.

CamDiab announced that it received European approval for its fully closed-loop automated insulin delivery algorithm. The algorithm enables users to manage their type 1 diabetes without counting carbohydrates or administering pre-meal insulin. CamDiab, based in Cambridge, UK, said it marks the world’s first commercially available automated insulin delivery algorithm that enables people with type 1 diabetes to use a fully closed-loop system.

CamDiab offers the FDA-approved mylife CamAPS FX app for automating insulin delivery in tandem with TecMed’s (formerly Ypsomed Diabetes Care’s) insulin delivery pumps. The mylife CamAPS FX app on iOS is fully compatible with leading continuous glucose monitors (CGMs). Those include the FreeStyle Libre 3 and Libre 3 Plus from Abbott and the Dexcom G6, so customers can use their preferred device.

“We are delighted to receive approval, which represents a significant step forward, introducing fully closed-loop insulin delivery into routine type 1 diabetes care. By removing the need for carb counting and pre-meal bolusing, we can meaningfully reduce diabetes distress and the relentless cognitive load associated with living with type 1 diabetes,” said Professor Roman Hovorka, director at CamDiab.

Read more: CamDiab earns CE mark for fully closed-loop insulin delivery algo

---

Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor by Senseonics Holdings, Inc., for Markets.FinancialContent.com, 29 January 2026.

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced CE Mark approval for the Eversense® 365 CGM system.  Eversense 365 is the world’s first and only one-year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of the same year.

The Eversense 365 CE Mark submission was prepared in compliance with the EU Medical Device Regulation (MDR) and is now approved for commercialization in the European Union (EU). The Company expects to launch Eversense 365 in Germany, Italy, Spain, and Sweden in the coming months.

“European approval for Eversense 365 represents the latest achievement in our long-term growth strategy for Senseonics and expands our total addressable market by over 30 million patients living with diabetes in the EU. As we take full ownership of all commercial activities for Eversense 365, we expect our expansion in Europe to contribute to top-line revenue growth, while offering a single year-long CGM solution to glucose monitoring,” said Tim Goodnow, PhD, President and Chief Executive Officer of Senseonics. “2026 will be an exciting year as we drive commercial progress in the U.S. and Europe, expect the impact of the integration with Sequel’s twiist™ Automated Insulin Delivery (AID) System in the U.S., and simultaneously await planned completion of the Gemini trial in the second half of the year.”

Read more: Senseonics Receives European Approval for Eversense 365

---

Dexcom G8: Dexcom CEO Hints at What to Expect From its Next-Gen Sensor byJustin Eastzer & Itzel Estrada for Diabetech.info, 26 January 2026.

Dexcom’s next-generation continuous glucose monitor (CGM), the Dexcom G8, is already in development but still a few years away from launch.  Dexcom CEO Jake Leach described G8 as a meaningful upgrade over G7 in accuracy, reliability, performance, size, and connectivity, calling it a completely new wearable. 

Size is a key change. According to Leach, the G8 sensor will be about 50 percent smaller than its predecessor, bringing it closer in size to the Freestyle Libre 3 Plus. Leach says the reduction is driven by advances in electronics, battery design, antennas, and power efficiency.  Leach also pointed out that Gestational diabetes is a key focus. He was direct in saying CGM should be the standard of care for pregnancies affected by gestational diabetes, citing strong evidence of better outcomes for both mothers and babies, including fewer NICU admissions and emergency C-sections.  Beyond pregnancy, Leach highlighted hospital use and prediabetes as major growth areas. Dexcom is already working toward broader hospital adoption, while prediabetes is being addressed through tools like the over-the-counter Stelo CGM. This sensor connects to the Oura ring to put glucose data alongside food, activity, sleep, and stress data.

Notably, Leach didn’t mention whether the upgraded sensor would track multiple analyses. Dexcom’s main competitor, Abbott, is working on a future dual glucose-ketone sensor.  Dexcom G7 just released a 15-day sensor, so the Dexcom G8 is not expected for a few years

Read more: Dexcom G8: Dexcom CEO Hints: What to Expect From Next-Gen Sensor

---

Is Chronic Inflammation Stealing Your Energy? Let’s Fix It. by Dr. Steve Edelman, Dr. Jeremy Pettus, and Dr. Jennie Luna for TCOYD.com, 26 January 2026.

What exactly is inflammation, and how do you know if it’s affecting your health? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with Dr. Jennie Luna, an endocrinologist specializing in obesity medicine and nutrition, to demystify inflammation and its connection to diabetes and metabolic health.

Together, they explore the differences between acute and chronic inflammation, why chronic inflammation often goes unnoticed despite affecting nearly every organ system, and how it drives conditions such as insulin resistance, fatty liver disease, and chronic kidney disease. Dr. Luna breaks down the warning signs—fatigue, brain fog, difficulty sleeping, and weight gain—and explains why these symptoms are so easy to miss.

The conversation shifts to actionable strategies you can implement today. From anti-inflammatory eating patterns and time-restricted eating to managing stress and prioritizing sleep, this episode focuses on practical, realistic changes that don’t require perfection or meal prep mastery.

---

Scientists May Have Finally Found the “Holy Grail” of Sugar Substitutes by Tufts University for SciTechDailiy.com, 14 January 2026.

Scientists have developed a new method to produce a rare sugar that tastes almost identical to table sugar but has far fewer health risks.  The result is a sweetener with fewer calories, minimal impact on blood sugar, and potential benefits for oral and gut health. It could offer a long-sought alternative to traditional sugar.

Researchers at Tufts University now report progress toward that goal. In a study published in Cell Reports Physical Science, the team describes a new biosynthetic method for producing tagatose, a naturally occurring but very rare sugar. Tagatose closely resembles table sugar in taste and could offer a way to sweeten foods with fewer negative effects. Scientists say it may also come with additional health benefits.

Tagatose provides about 92% of the sweetness of sucrose — table sugar — while containing roughly 60% fewer calories. It has been classified by the FDA as “generally recognized as safe,” meaning it can be used in consumer food products. This designation is the same one applied to common ingredients such as salt, vinegar, and baking soda.

One reason tagatose may be helpful for people with diabetes is how the body processes it. Only part of the sugar is absorbed in the small intestine, while much of it is fermented by gut bacteria in the colon. As a result, tagatose causes much smaller increases in blood glucose and insulin levels than conventional sugar. Clinical studies have shown minimal increases in plasma glucose or insulin after people consume tagatose.  Tagatose may also support oral health. Unlike sucrose, which feeds bacteria that contribute to cavities, tagatose appears to slow the growth of some of those microbes. Research also suggests it may have probiotic effects that support healthier bacteria in both the mouth and the gut.

Read more: Scientists May Have Finally Found the “Holy Grail” of Sugar Substitutes

---

Johns Hopkins University President Ron Daniels discusses living with diabetes, by Hub staff for JHU.edu, 26 January 2026.

Johns Hopkins University President Ron Daniels recently joined the “Diabetics Doing Things” podcast to discuss his personal experiences with Type 1 diabetes, how those experiences shape his leadership, and the vital role of research and innovation in delivering both therapeutic options and hope for those living with this chronic condition.

Daniels appeared as a guest on the podcast along with Sally Kornbluth, president of the Massachusetts Institute of Technology, who also has adult-onset Type 1 diabetes. The two have been friends since Kornbluth’s tenure as provost at Duke University, connecting over their experiences as higher education leaders who also manage an autoimmune disease that affects approximately 2.1 million people in the U.S.

Founded in 2015, “Diabetics Doing Things” aims to empower, inform, and inspire people living with diabetes through storytelling, events, and community. Its 345 podcast episodes produced over the past eight years have been downloaded more than 2 million times by listeners in more than 80 countries.

Read more: Johns Hopkins University President Ron Daniels on living with T1D

---

UVA Data Science researcher leads $4.7M project for AI-powered diabetes management by University of Virginia School of Data Science for news-medical.net, 27 January 2026.

University of Virginia School of Data Science researcher Heman Shakeri has been awarded a major new research grant to lead work at the intersection of machine learning and diabetes care. Shakeri will serve as a contact PI alongside Dr. Greg Forlenza, pediatric endocrinologist at the University of Colorado Anschutz Medical Campus (Barbara Davis Center for Diabetes).

The award is jointly funded by Breakthrough T1D and The Leona M. and Harry B. Helmsley Charitable Trust. The project leverages a $3.9 million grant combined with $800,000 in in-kind contributions from industry partners Tandem Diabetes Care and Arecor, bringing the total project support to approximately $4.7 million.

The initiative focuses on developing next-generation, fully closed-loop insulin delivery systems. The research will test how adaptive learning algorithms, developed at UVA, combined with ultra-rapid-acting insulin formulations, can personalize glucose control without requiring patients to manually intervene for meals or exercise.

Read more: UVA Data Science researcher leads $4.7M project: AI-powered D management

---

Check out TheSugarScience: a digital platform promoting scientific discussion as it pertains to T1D.  

WHAT WE DO:  We encourage scientists to speak both broadly and specifically about their work to:

• • ENCOURAGE trainees to further explore this approach and T1D research at large
  • MOTIVATE interdisciplinary scientist to think about T1D research from their perspectives
  • Pique the interest of T1D industry scientists with novel or excellent approaches
  • SPARK global collaboration amond scientis to accelerate T1D research
  • BUILD new T1D data repositories by connecting the right scientists

Founded by Monica Westley, PhD, in 2020, I’ve watched this amazing organization grow and connect researchers … and share their work.  Congratulations, Monica, for all your wonderful work!!!

About joining: If you are contacting them as a member of the general public with an interest in creating an account, please note that, in the interest of maintaining a high-level scientific space, they limit membership to scientists/clinicians. However, if you have a compelling interest in joining, please detail it below, and they will consider your application.  

Their weekly newsletter is always fascinating, fairly technical, and will spark your curiosity.  Sign Up for the Week In Review (WiR): TheSugarScience Week in Review

Read more: TheSugarScience

---

They Told Us We Wouldn’t Live This Long with T1D with Riva Greenberg by Ginger Vieira for DiabetesNerdNetwork.com, 22 January 2026.

Think type 1 diabetes (T1D) is a life-limiter?  Think again!  In this week’s episode of the Diabetes Nerd Podcast, we sit down with Riva Greenberg, an international speaker, thought partner, and advocate in diabetes.

Riva shares her 53-year journey with T1D: the tools and technology she’s used to manage it, the importance of CGMs, finding routine over the decades, and her community advocacy.  If you’re looking for some inspiration this Thursday, look no further! This episode is all you need to reignite your spark with T1D management in 2026.

---

Embracing sauna culture can lower dementia risk and boost brain health by Helen Thomson for NewScientist.com, 26 January 2026.

For science, I leveraged Scandinavian sauna culture while visiting Finland and Sweden last month. I also learned that “sauna” is pronounced “sow-na” (with the “ow” rhyming with “how”), rather than my south-east London pronunciation of “sorna”.  Finnish saunas, which are typically heated to between 70°C and 110°C (158°F to 230°F) and have low humidity, are the most well-studied. Regular use has been linked with many physical benefits – a lower risk of hypertension, muscular problems, and respiratory conditions, for instance. But now researchers are beginning to identify cognitive benefits as well. These improvements include fewer headaches, increased mental well-being, better sleep, and a lower risk of dementia.

In one of the largest studies, nearly 14,000 people were asked about their sauna use as part of a larger health study and were followed up 39 years later. After adjusting for other lifestyle factors, people who were more frequent sauna-goers – visiting a sauna nine to 12 times a month compared with less than four times a month – had a 19 per cent reduced risk of dementia by the end of the study. Beyond dementia, sauna bathing has also been linked to several other cognitive benefits, including:

• • • • significant improvement in chronic headache intensity
      • reduced risk of psychosis,
      • an increase in vitality
      • an ability to live life in a way that you personally value
      • social functioning in older adults

Heat therapy’s anti-inflammatory effects seem to be key to its many benefits. After controlling for factors like alcohol consumption and physical activity, the researchers found that frequent sauna sessions were associated with lower levels of several different inflammatory markers. The team concluded that sauna’s health benefits may partly stem from reduced inflammation, since chronic inflammation is strongly linked with depression, cognitive decline, and other neurological conditions.  

Another possible mechanism is heat shock. When your body temperature rises, due to exercise or passive heating, it triggers the production of heat shock proteins – molecules that act as chaperones for other proteins, ensuring they don’t misfold or go astray. These are critical, as misfolded proteins are a hallmark of many neurological conditions. 

To add some information about Type 1 diabetes and saunas: Is it safe for a person with diabetes to use a sauna? by Danielle Dresden for MedicalNewsToday.com, 18 August 2022.

As saunas use high temperatures, they also carry health risks. As such, it is advisable for people living with diabetes to be mindful, regularly check their blood sugars, and be ready to correct them if necessary. They can also consult their diabetes care team for advice.   Evidence notes that heat can affect diabetes in the following ways:

• • • • Dehydration: People with diabetes may lose water more quickly than others. Not drinking sufficient fluids can raise blood sugar. 
      • Difficulty cooling: If a person is unable to maintain their blood sugar within the target range, it can damage their blood vessels and nerves. This can affect a person’s sweat glands, making it difficult to cool effectively.
      • Insulin: High temperatures can alter how the body uses insulin. As metabolism increases in hotter weather, the body absorbs insulin more quickly. This means blood sugar levels decrease more quickly, increasing the risk of hypoglycemia.

Read more:

• • • • Embracing sauna culture can lower dementia risk and boost brain health
      • Is it safe for a person with diabetes to use a sauna?